The U.S. Food & Drug Administration’s decision to issue a news release requiring all ranitidine to be recalled from the market was the result of careful investigation. This research revealed that Ranitidine (or Zantac, as it is commonly known) contained an unacceptable level of N-Nitrosodimethylamine (NDMA), which can cause cancer.
In its April 1, 2020 release, “FDA Requests Removal of All Ranitidine Products (Zantac) from the Market,” the director of Center for Drug Evaluation and Research commented that the agency was making every effort possible to investigate potential health risks as well as to provide recommendations to the public based on available research.
The Role of NDMA
Small amounts of NDMA can be found in both food and water. In actuality, NDMA is commonly ingested as part of most people’s daily diets. NDMA only proves harmful when greater quantities are involved. While the FDA first believed that the small amount of NDMA in Ranitidine was minuscule enough to not prove harmful, the FDA later learned that the ranitidine in NDMA increases over time and with elevated pressure.
In actuality, the FDA did not notice unacceptable NDMA levels in many test samples. Because the FDA could not determine how long ranitidine products might have been stored, it decided that the medication should not be available to consumers unless its quality can be determined.
As a result of the FDA’s warning about ranitidine, 14 manufacturers pulled medications containing the substances from store shelves. These manufacturers include:
- American Health Packaging, Amneal Pharmaceuticals
- Apotex, Appco Pharma, Aurobindo Pharma USA
- Denton Pharma (dba Northwind Pharmaceuticals)
- Reddy’s Laboratories, Glenmark Pharmaceuticals
- Golden State Medical Supply
- Lannett, Novitium Pharma, Perrigo
- Precision Dose
Potential Harm Caused by NDMA
NDMA is known to cause various cancers including bladder cancer, colorectal cancer, gastric cancer, pancreatic cancer, and stomach cancer. While cancer is a serious illness, the risk that a person will develop cancer due to ranitidine is still low.
Besides the cancer risk, NDMA can also cause various other symptoms including abdominal cramps, dizziness, fever, hair loss, headaches, irregular heartbeat, jaundice, nervous-system disorders, skin rashes, and vomiting.
If you experience these or any other peculiar symptoms, you should not hesitate to speak with a medical professional.
The Basics of Zantac Cancer Lawsuits
Some Zantac manufacturers are currently facing class-action lawsuits from plaintiffs who claim that the companies were aware of the NDMA in ranitidine but who failed to disclose these details.
The United States Judicial Panel on Multidistrict Litigation also established a Zantac MDL in the United States District Court for Southern Florida. This means that all federally-initiated Zantac lawsuits will be consolidated into this MDL.
Some of the types of pain and damages alleged in these Zantac lawsuits include:
- Past and future loss of enjoyment of life
- Past and future medical expenses due to injuries
- Past and future wage reduction
- Punitive damages, in some situations
Speak with a Zantac Cancer Lawsuit Attorney
If you or a loved one has been harmed by Zantac, it can help to speak with a knowledgeable defective drug attorney. Contact The Law Offices of Cohen & Jaffe LLP today to schedule your free consultation.
For a free legal consultation, call 516-358-6900